Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Quanterix Corporation (QTRX)
NASDAQ:QTRX
Holding QTRX?
Track your performance easily
QTRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$10.50 - $29.70
Previous Close$13.2
Volume757.57K
Average Volume (3M)415.97K
Market Cap
$506.60M
Enterprise Value$249.32M
Total Cash (Recent Filing)$296.86M
Total Debt (Recent Filing)$39.58M
Price to Earnings (P/E)―
Beta1.47
Next Earnings
Nov 06, 2024EPS Estimate
-$0.24Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.04
Shares Outstanding38,379,033
10 Day Avg. Volume319,164
30 Day Avg. Volume415,969
Standard Deviation0.18
R-Squared0.15
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)1.50
Price to Sales (P/S)3.89
Price to Cash Flow (P/CF)-24.80
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.94
Enterprise Value/Gross Profit3.59
Enterprise Value/Ebitda-5.22
Forecast
1Y Price Target
$22.40Price Target Upside58.42% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
Quanterix News
Bulls Say, Bears Say
Bulls Say
Financial PerformanceQTRX's strong balance sheet with $299.5M cash and $0 debt, along with the Alzheimer's opportunity, is making the risk/reward more positive.
Partnerships4 new partnerships show continued momentum in driving adoption of Simoa in the clinic.
Technological AdvantageAnalysts believe QTRX has the most sensitive test of commercial stage peers, with the recent multi-marker launch only further widening the performance delta.
Bears Say
Competitor ActivityQTRX's stock has been particularly weak following competitor launch or partnership announcements in clinical Alzheimer's.
Industry WeaknessManagement continues to cite industry weakness likely to persist through year-end.
Revenue GuidanceThe company lowered its revenue guidance given macro headwinds.
---
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
QTRX FAQ
What was Quanterix Corporation’s price range in the past 12 months?
Quanterix Corporation lowest stock price was $10.50 and its highest was $29.70 in the past 12 months.
What is Quanterix Corporation’s market cap?
Currently, no data Available
When is Quanterix Corporation’s upcoming earnings report date?
Quanterix Corporation’s upcoming earnings report date is Nov 06, 2024 which is in 48 days.
How were Quanterix Corporation’s earnings last quarter?
Quanterix Corporation released its earnings results on Aug 08, 2024. The company reported -$0.25 earnings per share for the quarter, beating the consensus estimate of -$0.266 by $0.016.
Is Quanterix Corporation overvalued?
According to Wall Street analysts Quanterix Corporation’s price is currently Undervalued.
Does Quanterix Corporation pay dividends?
Quanterix Corporation does not currently pay dividends.
What is Quanterix Corporation’s EPS estimate?
Quanterix Corporation’s EPS estimate is -$0.24.
How many shares outstanding does Quanterix Corporation have?
Quanterix Corporation has 38,379,032 shares outstanding.
What happened to Quanterix Corporation’s price movement after its last earnings report?
Quanterix Corporation reported an EPS of -$0.25 in its last earnings report, beating expectations of -$0.266. Following the earnings report the stock price went down -14.821%.
Which hedge fund is a major shareholder of Quanterix Corporation?
Among the largest hedge funds holding Quanterix Corporation’s share is Gilder Gagnon Howe & Co LLC.. It holds Quanterix Corporation’s shares valued at 12M.
---
Quanterix Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$22.40 (58.42% Upside)
$22.40 (58.42% Upside)
Blogger Sentiment
Bullish
QTRX Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 548.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $831.7K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 2.3%
Last 30 Days ▼ 1.2%
Last 30 Days ▼ 1.2%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.69%
12-Months-Change
Fundamentals
Return on Equity
-11.48%
Trailing 12-Months
Asset Growth
-4.18%
Trailing 12-Months
Company Description
Quanterix Corporation
Quanterix Corp. is a life sciences company, which develops ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its Single Molecule Array (Simoa) technology platform uses single molecule measurements to access previously undetectable proteins. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Lexington, MA.
---
QTRX Company Deck
---
QTRX Earnings Call
Q2 2024
0:00 / 0:00
---
QTRX Stock 12 Month Forecast
Average Price Target
$22.40
▲(58.42% Upside)
Technical Analysis
Best Analysts Covering QTRX
1 Year
1 Year Success Rate
5/16 ratings generated profit
1 Year Average Return
-18.29%
reiterated a buy rating last month
Copying Sung Ji Nam's trades and holding each position for 1 Year would result in 31.25% of your transactions generating a profit, with an average return of -18.29% per trade.
---